Skip to content

Author

S. Okovity

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Efficacy and safety of liraglutide and semaglutide in obese children and adolescents: a systematic review

Objective. To evaluate efficacy and safety of glucagon-like peptide-1 receptor agonists (liraglutide and semaglutide) for the treatment of obesity in children and adolescents. Material and methods. A systematic review was conducted in accordance with the PRISMA 2020 recommendations. We searched publications in PubMed,...

E. A. Kovaleva, O. Nemyatykh, S. Okovity et al. · 0 citations
Open access Oct 2026

Metabolic-associated fatty liver disease and hypertriglyceridemia: cardiovascular risks and current therapeutic approaches

Metabolic-associated fatty liver disease (MAFLD) is a systemic disorder associ-ated with metabolic dysfunction and a high risk of life-threatening conditions, primarily cardiovascular disease. MAFLD is often accompanied by hypertriglyceridemia (HTG), as both conditions share a common pathogenetic mechanism — insulin re...

Y. Khalimov, M. Yezhov, K. Raikhelson et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.